What is the correct dose of nitrofurantoin (antibiotic) for a urinary tract infection (UTI) caused by Enterococcus faecalis with a minimum inhibitory concentration (MIC) of <=16?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin Dosing for UTI Caused by Enterococcus faecalis

For uncomplicated urinary tract infections caused by Enterococcus faecalis with susceptibility ≤16, nitrofurantoin should be dosed at 100 mg PO every 6 hours. 1

Recommended Dosing Regimen for Enterococcus UTIs

  • For uncomplicated UTIs due to vancomycin-resistant enterococci (VRE), nitrofurantoin 100 mg PO every 6 hours is recommended (Weak recommendation, very low quality of evidence) 1
  • This dosing regimen is also appropriate for susceptible Enterococcus faecalis with MIC ≤16 2
  • For standard uncomplicated UTIs not specifically caused by enterococci, the more common dosing is nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days 3

Efficacy Against Enterococcus faecalis

  • Nitrofurantoin demonstrates excellent in vitro activity against enterococci, with 88% of isolates showing susceptibility 4
  • No enterococci isolates, including vancomycin-resistant strains, have shown resistance to nitrofurantoin in some studies (MIC ≥128 μg/mL) 2
  • Nitrofurantoin maintains efficacy against multidrug-resistant enterococci, including VRE strains 5
  • For E. faecalis specifically, MIC50 is 8 μg/mL and MIC90 is 64 μg/mL, indicating good susceptibility 5

Important Clinical Considerations

  • Nitrofurantoin is contraindicated in patients with creatinine clearance <60 mL/min due to inadequate urinary drug concentrations and increased toxicity risk 6
  • For patients with renal impairment, alternative agents such as trimethoprim-sulfamethoxazole or fosfomycin should be considered 6
  • Common side effects include nausea and headache, with adverse event rates ranging from 5.6-34% 3
  • Nitrofurantoin should be avoided if early pyelonephritis is suspected 3

Duration of Therapy

  • While the standard duration for uncomplicated UTIs is 5-7 days 3, for enterococcal UTIs specifically, treatment should be continued until clinical resolution, typically 7-10 days 1
  • Clinical cure rates with nitrofurantoin range from 88-93% for uncomplicated UTIs 3

Alternative Options for Enterococcal UTIs

  • If nitrofurantoin cannot be used, fosfomycin 3 g PO as a single dose is an alternative for uncomplicated UTIs due to VRE 1, 5
  • High-dose ampicillin (18-30 g IV daily in divided doses) or amoxicillin 500 mg IV or PO every 8 hours are other alternatives for uncomplicated UTIs due to VRE 1

Monitoring

  • Routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients 3
  • For women whose symptoms do not resolve by the end of treatment or recur within 2 weeks, a urine culture with susceptibility testing should be performed 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nitrofurantoin is active against vancomycin-resistant enterococci.

Antimicrobial agents and chemotherapy, 2001

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

In-vitro activity of nitrofurantoin in enterococcus urinary tract infection.

JPMA. The Journal of the Pakistan Medical Association, 2004

Guideline

Nitrofurantoin Dosing Considerations in Adults with UTIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.